GLENMEDE TRUST CO NA - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 152 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$13,000
-59.4%
5,454
+128.7%
0.00%
Q2 2020$32,000
+14.3%
2,385
-47.1%
0.00%
Q1 2020$28,0000.0%4,5060.0%0.00%
Q4 2019$28,000
+27.3%
4,506
-22.9%
0.00%
Q3 2019$22,000
-24.1%
5,847
-5.8%
0.00%
Q2 2019$29,000
-40.8%
6,2100.0%0.00%
Q1 2019$49,000
+104.2%
6,210
+37.8%
0.00%
Q4 2018$24,0004,5060.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$1,471,0001.42%
Orchard Capital Management, LLC 251,826$80,0000.03%
GSA CAPITAL PARTNERS LLP 486,568$154,0000.02%
Icon Wealth Advisors, LLC 400,132$1270.02%
ACADIAN ASSET MANAGEMENT LLC 7,483,053$2,365,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,042,816$646,0000.01%
WIPFLI FINANCIAL ADVISORS LLC, 200,000$63,0000.00%
WEALTH EFFECTS LLC 18,316$6,0000.00%
James J. Burns & Company, LLC 25,142$8,0000.00%
Bayesian Capital Management, LP 68,600$22,0000.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders